5 steps to secure funding for ophthalmic product development

Lexitas CEO and Chairwoman, Jeanne Hecht, shares her veteran insights into funding for ophthalmic product development. This article with Ophthalmology 360 details the 5 steps innovators can take to maximize both their chances of securing funding and the strength of their partnerships.

About Jeanne Hecht:
Jeanne Taylor Hecht is Lexitas’ Chief Executive Officer and Chairwoman of the Board of Directors. Her industry career spanned over twenty-five years as Board member and Chief Executive Officer of multiple companies, including CEO at Ora and senior executive at companies such as Median Technologies, IQVIA, Decision Biomarkers, and the UNC Oncology Protocol Office. Jeanne also launched and expanded a Life Sciences consulting practice that supported companies with sales, marketing, and market growth strategies as well as advisory and board work. She is primarily motivated by helping to bring relief to patients. Jeanne is an active Advisory Board Member for the University of North Carolina Chapel Hill Kenan-Flagler’s Business School and lecturer at the business school. She contributed to the creation of Wake Forest University’s master’s in clinical research program and remains an active industry advisor to the school. She holds a Bachelor of Science from the University of Michigan and a Master of Business Administration from that university’s Ross School of Business.

Our Visionary Insights newsletter is published once a month and has thousands of subscribers. To stay in touch, subscribe today.